Reprise License Manager up to 12.2BL2 /goform/edit_lf_get_data lf cross site scripting ⚔ [Disputed]
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.5 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in Reprise License Manager up to 12.2BL2. Impacted is an unknown function of the file /goform/edit_lf_get_data. Executing a manipulation of the argument lf as part of Parameter can lead to cross site scripting. This vulnerability is registered as CVE-2018-15574. It is possible to launch the attack remotely. No exploit is available. The actual existence of this vulnerability is currently in question.
Details
A vulnerability classified as problematic was found in Reprise License Manager up to 12.2BL2. This vulnerability affects an unknown functionality of the file /goform/edit_lf_get_data. The manipulation of the argument lf as part of a Parameter leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
** DISPUTED ** An issue was discovered in the license editor in Reprise License Manager (RLM) through 12.2BL2. It is a cross-site scripting vulnerability in the /goform/edit_lf_get_data lf parameter via GET or POST. NOTE: the vendor has stated "We do not consider this a vulnerability."
The weakness was published 08/20/2018 (Website). The advisory is shared for download at bittherapy.net. This vulnerability was named CVE-2018-15574 since 08/19/2018. The attack can be initiated remotely. No form of authentication is required for a successful exploitation. Successful exploitation requires user interaction by the victim. There are known technical details, but no exploit is available. The MITRE ATT&CK project declares the attack technique as T1059.007.
The real existence of this vulnerability is still doubted at the moment.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Similar entry is available at VDB-123039. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.5VulDB Meta Temp Score: 5.5
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CNA Base Score: 6.1
CNA Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
Timeline
08/19/2018 🔍08/19/2018 🔍
08/20/2018 🔍
08/20/2018 🔍
08/05/2024 🔍
Sources
Advisory: bittherapy.netStatus: Not defined
Disputed: 🔍
CVE: CVE-2018-15574 (🔍)
GCVE (CVE): GCVE-0-2018-15574
GCVE (VulDB): GCVE-100-123040
See also: 🔍
Entry
Created: 08/20/2018 08:35Updated: 08/05/2024 15:46
Changes: 08/20/2018 08:35 (41), 03/16/2020 20:14 (18), 08/05/2024 15:46 (28)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.